Rule CG-DIS-028
Disease claims: what rule CG-DIS-028 checks
Rule CG-DIS-028 is one of the checker's disease claims rules. It cites 21 CFR 101.93(g). The reason, source and safer wording are below.
CG-DIS-028 · Blocks approval · Citation checked against stored text
Comparing a supplement to a GLP-1 prescription drug ("natural Mounjaro", "mimics Ozempic") claims drug-like effects on weight and blood sugar and implies the product does what an approved drug does.
Source: FDCA 201(g)(1); 21 CFR 101.93(g); FTC Act section 5; FTC Health Products Compliance Guidance
Safer wording: Do not name or compare to a prescription drug. Describe the ingredients.
21 CFR 101.93(g) · Needs counsel review
Next step
Check your copy against this rule
Run the checker and every flag cites its rule and source.